Jiangsu Nhwa Pharmaceutical Co., LTD (SHE: 002262)
China
· Delayed Price · Currency is CNY 26.56
+0.56 (2.15%)
Nov 15, 2024, 3:04 PM CST
Jiangsu Nhwa Pharmaceutical Co., LTD Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 26,990 | 27,326 | 24,736 | 15,769 | 16,092 | 11,855 | Upgrade
|
| Market Cap Growth | 3.67% | 10.47% | 56.87% | -2.01% | 35.74% | 28.86% | Upgrade
|
| Enterprise Value | 23,230 | 23,972 | 21,956 | 13,322 | 13,929 | 11,014 | Upgrade
|
| Last Close Price | 26.56 | 26.77 | 24.06 | 15.09 | 15.31 | 11.08 | Upgrade
|
| PE Ratio | 22.89 | 25.99 | 27.04 | 19.11 | 21.26 | 16.78 | Upgrade
|
| Forward PE | 20.27 | 22.41 | 24.31 | 17.58 | 18.30 | 17.86 | Upgrade
|
| PS Ratio | 4.85 | 5.42 | 5.75 | 4.01 | 4.79 | 2.86 | Upgrade
|
| PB Ratio | 3.73 | 4.26 | 4.43 | 3.22 | 3.92 | 3.29 | Upgrade
|
| P/TBV Ratio | 4.01 | 4.38 | 4.49 | 3.27 | 4.00 | 3.37 | Upgrade
|
| P/FCF Ratio | 40.12 | 43.08 | 46.39 | 31.86 | 16.43 | 81.38 | Upgrade
|
| P/OCF Ratio | 25.15 | 27.10 | 28.73 | 22.49 | 12.89 | 38.75 | Upgrade
|
| PEG Ratio | 1.27 | 1.66 | 1.66 | 1.66 | 0.87 | 1.12 | Upgrade
|
| EV/Sales Ratio | 4.20 | 4.75 | 5.11 | 3.38 | 4.14 | 2.65 | Upgrade
|
| EV/EBITDA Ratio | 16.76 | 19.90 | 21.43 | 13.88 | 15.86 | 14.19 | Upgrade
|
| EV/EBIT Ratio | 19.15 | 22.41 | 24.35 | 15.72 | 17.82 | 16.01 | Upgrade
|
| EV/FCF Ratio | 34.53 | 37.79 | 41.17 | 26.91 | 14.22 | 75.61 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.08 | 0.09 | 0.09 | 0.11 | 0.04 | 0.05 | Upgrade
|
| Debt / FCF Ratio | 0.17 | 0.18 | 0.17 | 0.22 | 0.04 | 0.26 | Upgrade
|
| Asset Turnover | 0.72 | 0.73 | 0.71 | 0.75 | 0.75 | 1.01 | Upgrade
|
| Inventory Turnover | 2.25 | 2.09 | 1.57 | 1.80 | 2.16 | 4.13 | Upgrade
|
| Quick Ratio | 5.61 | 5.64 | 4.88 | 5.01 | 4.99 | 5.08 | Upgrade
|
| Current Ratio | 6.38 | 6.46 | 5.86 | 5.93 | 5.77 | 5.82 | Upgrade
|
| Return on Equity (ROE) | 17.46% | 17.25% | 16.78% | 17.72% | 18.86% | 20.03% | Upgrade
|
| Return on Assets (ROA) | 9.93% | 9.68% | 9.25% | 10.14% | 10.92% | 10.45% | Upgrade
|
| Return on Capital (ROIC) | 11.18% | 10.96% | 10.54% | 11.56% | 12.55% | 12.43% | Upgrade
|
| Earnings Yield | 4.37% | 3.79% | 3.64% | 5.06% | 4.53% | 5.59% | Upgrade
|
| FCF Yield | 2.49% | 2.32% | 2.16% | 3.14% | 6.09% | 1.23% | Upgrade
|
| Dividend Yield | 1.23% | 1.20% | 0.83% | 1.33% | 0.65% | 0.90% | Upgrade
|
| Payout Ratio | 27.43% | 19.43% | 22.37% | 12.63% | 13.98% | 11.63% | Upgrade
|
| Buyback Yield / Dilution | 0.54% | 0.53% | -0.22% | 0.24% | -0.72% | 0.42% | Upgrade
|
| Total Shareholder Return | 1.78% | 1.72% | 0.61% | 1.56% | -0.07% | 1.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.